Immunological ignorance of solid tumors - PubMed (original) (raw)

Review

Immunological ignorance of solid tumors

Adrian F Ochsenbein. Springer Semin Immunopathol. 2005 Jun.

Abstract

Many peripheral solid tumors such as sarcomas and carcinomas express tumor-specific antigens that can serve as targets for immune effector T cells. Nevertheless, the immune surveillance against clinically manifest carcinomas and sarcomas seems relatively inefficient. Naïve cytotoxic T cells are activated exclusively in secondary lymphoid organs including the spleen and lymph nodes. Tumor antigen might be either cross-presented to naïve cytotoxic T cells by professional antigen-presenting cells (pAPC), or presented directly by tumor cells that migrated to secondary lymphoid organs. Direct priming is quite inefficient during early tumor development because metastasis to lymphoid organs is usually limited to advanced stage diseases. Similarly, the process of cross-priming by pAPC seems to depend on relatively large antigen amounts and on maturation stimuli for dendritic cells, and both requirements may be limiting during initial tumorigenesis. Therefore, the immunosurveillance of solid tumors may fail because they are ignored for too long by the immune system. However, these situations may prove promising for the induction of tumor-specific T cell immunity by vaccination, as the T cell repertoire against these antigens has a naïve phenotype and is not yet affected by tolerance mechanisms.

PubMed Disclaimer

Similar articles

• Immune surveillance against a solid tumor fails because of immunological ignorance.
  Ochsenbein AF, Klenerman P, Karrer U, Ludewig B, Pericin M, Hengartner H, Zinkernagel RM. Ochsenbein AF, et al. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2233-8. doi: 10.1073/pnas.96.5.2233. Proc Natl Acad Sci U S A. 1999. PMID: 10051624 Free PMC article.
• Principles of tumor immunosurveillance and implications for immunotherapy.
  Ochsenbein AF. Ochsenbein AF. Cancer Gene Ther. 2002 Dec;9(12):1043-55. doi: 10.1038/sj.cgt.7700540. Cancer Gene Ther. 2002. PMID: 12522443 Review.
• Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.
  Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, Hemmi S, Hengartner H, Zinkernagel RM. Ochsenbein AF, et al. Nature. 2001 Jun 28;411(6841):1058-64. doi: 10.1038/35082583. Nature. 2001. PMID: 11429607
• [Dendritic cells and immune function in cancer].
  Chaux P. Chaux P. Pathol Biol (Paris). 1995 Dec;43(10):897-903. Pathol Biol (Paris). 1995. PMID: 8786896 Review. French.
• Induction of antigen-specific effector-phase tolerance following vaccination against a previously ignored B-cell lymphoma.
  Prato S, Mintern JD, Lahoud MH, Huang DC, Villadangos JA. Prato S, et al. Immunol Cell Biol. 2011 Jul;89(5):595-603. doi: 10.1038/icb.2010.131. Epub 2010 Nov 16. Immunol Cell Biol. 2011. PMID: 21079642

Cited by

• Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance.
  Gao X, Wu Y, Chick JM, Abbott A, Jiang B, Wang DJ, Comte-Walters S, Johnson RH, Oberholtzer N, Nishimura MI, Gygi SP, Mehta A, Guttridge DC, Ball L, Mehrotra S, Sicinski P, Yu XZ, Wang H. Gao X, et al. Cell Rep. 2023 Apr 25;42(4):112314. doi: 10.1016/j.celrep.2023.112314. Epub 2023 Mar 30. Cell Rep. 2023. PMID: 37000627 Free PMC article.
• New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
  Rapti V, Tsaganos T, Vathiotis IA, Syrigos NK, Li P, Poulakou G. Rapti V, et al. Vaccines (Basel). 2022 Sep 25;10(10):1607. doi: 10.3390/vaccines10101607. Vaccines (Basel). 2022. PMID: 36298472 Free PMC article. Review.
• The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors.
  Blair TC, Alice AF, Zebertavage L, Crittenden MR, Gough MJ. Blair TC, et al. Front Oncol. 2021 Apr 22;11:653625. doi: 10.3389/fonc.2021.653625. eCollection 2021. Front Oncol. 2021. PMID: 33968757 Free PMC article. Review.
• The Origin and Immune Recognition of Tumor-Specific Antigens.
  Apavaloaei A, Hardy MP, Thibault P, Perreault C. Apavaloaei A, et al. Cancers (Basel). 2020 Sep 12;12(9):2607. doi: 10.3390/cancers12092607. Cancers (Basel). 2020. PMID: 32932620 Free PMC article. Review.
• Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines.
  Šošić L, Selbo PK, Kotkowska ZK, Kündig TM, Høgset A, Johansen P. Šošić L, et al. Cancers (Basel). 2020 Jan 9;12(1):165. doi: 10.3390/cancers12010165. Cancers (Basel). 2020. PMID: 31936595 Free PMC article. Review.

References

1. 1. J Exp Med. 2002 Feb 18;195(4):423-35 - PubMed
2. 1. Immunity. 2002 Dec;17(6):737-47 - PubMed
3. 1. Nat Immunol. 2004 Jul;5(7):678-84 - PubMed
4. 1. J Exp Med. 2002 Jan 7;195(1):125-33 - PubMed
5. 1. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16168-73 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Springer